FDA Approval Won't Make Stem Cell Therapy Cheaper | #195

If you're holding off on stem cell therapy because you're waiting for FDA approval to bring the price down, this is the reality check you need.

Dr. Joy Kong, a triple board certified physician and stem cell specialist at Chara Health, breaks down what FDA approved stem cell products actually cost. Cord blood transplants like Omidacel and AlloCord run $450,000 to $1.2 million. Ryoncil, used for pediatric graft versus host disease, totals $1.55 million. By comparison, current stem cell therapy provided as a legal tissue transplant, the same model used in organ transplants, costs $7,000 to $25,000 per infusion.

Dr. Joy explains why that gap exists, and what it means if you're counting on insurance to make this treatment affordable.

✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/

Dr. Joy talks about:

0:21 Why FDA Approval Doesn't Lower Cost

2:26 Cost Of FDA-Approved Stem Cell Products

3:40 Why Legal Stem Cell Therapy Is Cheaper

Additional Resources

Visit My Clinic: Chara Health

🌐 https://chara-health.com

📍 9568 Topanga Canyon Blvd. Los Angeles, CA 91311